HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preoperative plasma levels of prothrombin fragment 1 + 2 correlate with the risk of venous thrombosis after elective hip replacement.

Abstract
Better preoperative identification of those patients at high risk of developing a deep vein thrombosis (DVT) after hip surgery could reduce the incidence of this postoperative complication, which still occurs despite prophylaxis. One hundred fifty-nine patients undergoing elective total hip replacement and given anticoagulant prophylaxis, were investigated, looking for the presence of a hypercoagulable state, that represents one element of Virchow's triad predisposing to DVT. Plasma levels of three markers of coagulation activation, namely prothrombin fragment 1 + 2 (F1 + 2), thrombin-antithrombin III complexes (TAT) and D-dimer were measured using ELISA procedures and were correlated with the results of the postoperative phlebography. A high correlation (p < 0.001) between the preoperative plasma levels of F1 + 2 and the risk of postoperative venous thromboembolism was detected. The performance of TAT and D-dimer levels in predicting DVT was lower. These findings support the hypothesis that preoperative measurement of coagulation activation markers might be useful in predicting DVT following a total hip replacement.
AuthorsA Corradi, F Lazzaro, E Cofrancesco, M Cortellaro, F Ravasi, F Bertocchi
JournalActa orthopaedica Belgica (Acta Orthop Belg) Vol. 65 Issue 1 Pg. 39-43 (Mar 1999) ISSN: 0001-6462 [Print] Belgium
PMID10217000 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
  • Peptide Fragments
  • Prothrombin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Arthroplasty, Replacement, Hip (adverse effects)
  • Biomarkers (analysis)
  • Elective Surgical Procedures (adverse effects)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments (blood)
  • Postoperative Complications
  • Prothrombin (analysis)
  • Risk Factors
  • Venous Thrombosis (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: